IL5 and allergic asthma: Intragastric administration of 1-MID in doses of 40 and 80 mg/kg BW to a rat model of ovalbumin-induced allergic asthma for 7 days significantly decreased contents of IL-5 and eotaxin as well as eosinophil count in BALF.